PIKFYVE and rheumatoid arthritis: Apilimod is a selective PIKfyve inhibitor (38), which abrogates the synthesis of IL-12 and IL-23 in patients with Crohn’s disease (CD) (39), rheumatoid arthritis (RA) (40), and psoriasis (41).